Moxivig (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxivig, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in adult and pediatric patients by inhibiting bacterial DNA replication, leading to rapid bacterial clearance.

GNH USA supplies Moxivig as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxivig is indicated for bacterial infections of the eye, targeting common ocular pathogens.

- Bacterial conjunctivitis: reduces bacterial load and speeds symptom relief in acute conjunctival infection. - Bacterial keratitis: eradicates pathogenic bacteria in corneal ulcers, promoting healing. - Post‑operative ocular infection prophylaxis: prevents bacterial colonisation after eye surgery, reducing postoperative infection risk.

Moxivig may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Tearing or increased lacrimation. - Foreign body sensation. - Blurred vision. - Mild headache.

Serious or Rare Side Effects: - Allergic reactions such as swelling, rash, or anaphylaxis. - Corneal ulceration or thinning. - Severe ocular inflammation or uveitis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic hypersensitivity reactions. - Vision loss if severe complications develop.

Before prescribing Moxivig, consider patient‑specific factors and safety measures.

- Allergy assessment: avoid in patients with known fluoroquinolone hypersensitivity. - Contact lens wearers: remove lenses before instillation and avoid re‑wearing until after treatment. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Drug interactions: avoid concurrent use with other ophthalmic antibiotics unless directed. - Monitoring: watch for worsening infection or signs of severe ocular reaction. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxivig can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: additive risk of tendon toxicity. - Topical corticosteroids: may mask infection progression.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce drug absorption. - Non‑steroidal anti‑inflammatory eye drops: may increase local irritation. - Other ophthalmic antibiotics: potential antagonism or reduced efficacy.